Skip to search formSkip to main contentSkip to account menu

regadenoson

Known as: (1-(9-(3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-6-aminopurin-2-yl)pyrazol-4-yl)-N-methylcarboxamide, Adenosine, 2-(4-((methylamino)carbonyl)-1H-pyrazol-1-yl)- 
An adenosine derivative and selective A2A adenosine receptor agonist with coronary vasodilating activity. Upon administration, regadenoson… 
National Institutes of Health

Related topics

Related topics

6 relations

Broader (3)

Adenosine A2 Receptor AgonistsPurinesPyrazoles
Adenosine Receptor Agonists [MoA]regadenoson 0.08 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION [LEXISCAN]

Narrower (1)

CVT 3146

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Accelerated dual‐contrast first‐pass perfusion MRI of the mouse heart: Development and application to diet‐induced obese mice
Gene‐modified mice may be used to elucidate molecular mechanisms underlying abnormal myocardial blow flow (MBF). We sought to… 
2013
2013
Regadenoson pharmacologic rubidium-82 PET: A comparison of quantitative perfusion and function to dipyridamole
BackgroundDipyridamole is used for stress 82rubidium chloride (82RbCl) PET because of its long hyperemic duration. Regadenoson… 
2013
2013
A strategy of symptom-limited exercise with regadenoson-as-needed for stress myocardial perfusion imaging: A randomized controlled trial
BackgroundAmbulatory patients with uncertain functional capacity may benefit from combined exercise and vasodilator stress… 
2013
2013
Regadenoson pharmacologic stress for myocardial perfusion imaging: A three-way comparison between regadenoson administered at peak exercise, during walk recovery, or no-exercise
BackgroundRegadenoson (Reg) is being administered with increasing frequency either at peak exercise (ExPeak-Reg) or during a slow… 
2013
2013
Reclassification of cardiovascular risk in patients with normal myocardial perfusion imaging using heart rate response to vasodilator stress.
2012
2012
Safety and feasibility of regadenoson use for suboptimal heart rate response during symptom-limited standard Bruce exercise stress test
BackgroundRegadenoson during exercise stress test (ETT) can provide maximal hyperemia for myocardial perfusion imaging (MPI… 
2011
2011
Comparison of the myocardial blood flow response to regadenoson and dipyridamole: a quantitative analysis in patients referred for clinical 82Rb myocardial perfusion PET
BackgroundRegadenoson is a novel selective A2A adenosine receptor agonist, which is administered as an intravenous bolus at a… 
2007
2007
Caffeine Attenuates the Duration of Coronary Vasodilation and Changes in Hemodynamics Induced by Regadenoson (CVT-3146), a Novel Adenosine A2A Receptor Agonist
Effects of caffeine on regadenoson-induced coronary vasodilation and changes in hemodynamics were examined in conscious dogs… 
2005
2005
Improving the antiviral efficacy and selectivity of HIV-1 reverse transcriptase inhibitor TSAO-T by the introduction of functional groups at the N-3 position.
Novel derivatives of the anti-HIV-1 agent, TSAO-T, bearing at the N-3 position a variety of polar, lipophilic, or aromatic groups… 
1994
1994
Selective ligands for rat A3 adenosine receptors: structure-activity relationships of 1,3-dialkylxanthine 7-riboside derivatives.
1,3-Dibutylxanthine 7-riboside has been found to be a partial agonist at A3 adenosine receptors (van Galen et al. Mol. Pharmacol… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)